Journal of Neurophysiology, Vol 70, Issue 6 2673-2677, Copyright © 1993 by APS

ARTICLES

Protoporphyrins modulate voltage-gated Ca current in AtT-20 pituitary cells

D. J. Linden, K. Narasimhan and D. Gurfel
Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

1. Zinc-protoporphyrin-IX (ZnPP-IX) is an inhibitor of the enzyme heme-oxygenase-2 (HO-2) and consequently has been used to examine the role of carbon monoxide production in neural tissues. We have measured voltage-gated Ca current in AtT-20 pituitary cells using the whole-cell patch-clamp technique and have assessed the effects of extracellularly applied ZnPP-IX and related compounds. 2. Ca currents evoked by depolarizing steps from a holding potential of -90 mV were of the high-threshold, slowly inactivating type. Fifty-six percent of this current was blocked by 10 microM nifedipine and 16% by 3 microM omega-conotoxin with the remainder resistant to both drugs in combination, suggesting that the total Ca current was a mixture of L, N, and possibly P-type conductances. 3. Bath application of ZnPP-IX resulted in an irreversible, dose-dependent attenuation of Ca current. Five micromolar ZnPP-IX produced a 62% reduction of peak current amplitude with no shift in the current-voltage relation, 0.5 microM produced a 19% reduction, and 0.05 microM produced a variable response, either a small transient attenuation or potentiation. 4. The attenuation of Ca current by 5 microM ZnPP-IX could be nearly completely blocked by co-application of superoxide dismutase in the bath (90 U/ml) but not by addition of an inhibitor of cGMP-dependent protein kinase to the internal saline (KT5823, 1 microM). 5. Other inhibitors of heme-oxygenase with similar potency such as tin-protoporphyrin-IX (Sn-PP-IX) and Zn-deuteroporphyrin-bis-glycol (ZnBG) did not attenuate Ca current when applied at 5microM.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				C. W. Leffler, H. Parfenova, J. H. Jaggar, and R. Wang Carbon monoxide and hydrogen sulfide: gaseous messengers in cerebrovascular circulation J Appl Physiol, March 1, 2006; 100(3): 1065 - 1076. [Abstract] [Full Text] [PDF]

				L. Wu and R. Wang Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications Pharmacol. Rev., December 1, 2005; 57(4): 585 - 630. [Abstract] [Full Text] [PDF]

				H. ZHUANG, Y.-S. KIM, R. C. KOEHLER, and S. DORE Potential Mechanism by Which Resveratrol, a Red Wine Constituent, Protects Neurons Ann. N.Y. Acad. Sci., May 1, 2003; 993(1): 276 - 286. [Abstract] [Full Text] [PDF]

				H. Zhuang, S. Pin, X. Li, and S. Dore Regulation of Heme Oxygenase Expression by Cyclopentenone Prostaglandins Experimental Biology and Medicine, May 1, 2003; 228(5): 499 - 505. [Abstract] [Full Text] [PDF]

				W. Durante Carbon monoxide and bile pigments: surprising mediators of vascular function Vascular Medicine, August 1, 2002; 7(3): 195 - 202. [Abstract] [PDF]

				M. Zhuo, J. T. Laitinen, X.-C. Li, and R. D. Hawkins On the Respective Roles of Nitric Oxide and Carbon Monoxide in Long-Term Potentiation in the Hippocampus Learn. Mem., January 1, 1999; 6(1): 63 - 76. [Abstract] [Full Text]

				M. Zhuo, J. T. Laitinen, X.-C. Li, and R. D. Hawkins On the Respective Roles of Nitric Oxide and Carbon Monoxide in Long-Term Potentiation in the Hippocampus Learn. Mem., November 1, 1998; 5(6): 467 - 480. [Abstract] [Full Text]